MeSH Browser

MeSH Supplementary: axicabtagene ciloleucel
Unique ID: C000629083
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000629083
Entry Term(s): KTE-C19; Yescarta
Pharm Action: Antineoplastic Agents, Immunological
Registry Numbers: U2I8T43Y7R
Heading Mapped to: *Biological Products
Frequency: 160
Note: CD19 CAR T cell therapy for treatment of relapsed refractory diffuse large B cell lymphoma (DLBCL), high grade lymphoma, and primary mediastinal B cell lymphoma (PMBCL)
Source: Med Lett Drugs Ther. 2018 Jul 16;60(1551):e122-e123.
Date of Entry: 2018/11/28
Revision Date: 2021/10/03

axicabtagene ciloleucel MeSH Supplementary Concept Data 2025